Navigation Links
New Sackler Institute and Chair for Translational Neurodevelopment at King's College London
Date:7/25/2013

King's College London has received a transformative gift from the Dr. Mortimer and Theresa Sackler Foundation to establish the Dr. Mortimer D. Sackler Chair in Translational Neurodevelopment and the Sackler Institute for Translational Neurodevelopment.

As a result of this gift we are delighted to announce that Professor Declan Murphy, Head of the Department of Forensic and Neurodevelopmental Science at the Institute of Psychiatry (IoP) at King's has been appointed the Dr. Mortimer D. Sackler Chair in Translational Neurodevelopment and will lead the new Institute.

The Sackler Institute for Translational Neurodevelopment aims to transform our understanding of how disorders such as autism spectrum disorder, epilepsy and Down's syndrome develop over a lifespan, to improve diagnostic approaches and to develop innovative treatments for these disorders.

King's has an established reputation in neurodevelopmental research and the creation of the Sackler Institute for Translational Neurodevelopment will allow for greater collaboration between research teams across King's and drive the translation of findings into patient benefit.

Based at Institute of Psychiatry at King's the new Sackler Institute aims to:

  • Advance our understanding of the origin, biological mechanism and lifespan evolution of challenging neurodevelopmental disorders
  • Develop and evaluate novel diagnostic and treatment biomarkers to create individualised medicine
  • Discover and test novel psychopharmacologic, behavioural and bioengineering interventions
  • Pioneer genetic and cell therapies and offer state-of-the-art genetic counselling
  • Foster interdisciplinary research training of postdoctoral students and clinicians

Professor Sir Rick Trainor, Principal of King's College London says: "We are hugely honoured and grateful to the Sackler Foundation for this gift. Improving our understanding of neurological disorders and developing treatments for them, are central pillars of King's research. This major gift will allow us to harness this expertise and translate and expedite discoveries into patient care."

Dame Theresa Sackler of the Dr. Mortimer and Theresa Sackler Foundation, says: "We are delighted to hear that Professor Declan Murphy has been appointed the Dr. Mortimer D. Sackler Chair in Translational Neurodevelopment and we wish Professor Murphy and his team of scientists great success in challenging and resolving Neurodevelopmental disorders in their work at The Sackler Institute for Translational Neurodevelopment at King's."

Professor Shitij Kapur, Dean and Head of School of the IoP at King's says: "We are very grateful to the Sackler Foundation for their generous donation and honoured that this exciting new centre will be based at the IoP. We are delighted to appoint Professor Murphy as the Dr. D Mortimer Sackler Chair in Translational Neurodevelopment. He is a world leader in this field and is reaching out to some of the most distinguishing scientists at King's to develop the Sackler Institute faculty. This will help attract the best minds to work on innovative solutions to complex problems."

Professor Declan Murphy, Dr. D Mortimer Sackler Chair in Translational Neurodevelopment and Head of the Department of Forensic and Neurodevelopmental Science at the IoP at King's, says: "I am honoured to have been offered this position. I look forward to working with colleagues across King's, other Sackler Centres and international networks to translate new findings from basic science into treatment advances."

The Sackler Institute for Translational Neurodevelopment will become the fourth Sackler Institute in the UK, and the second at King's, joining the Sackler Institute of Pulmonary Pharmacology.


'/>"/>

Contact: Seil Collins
seil.collins@kcl.ac.uk
44-207-848-5377
King's College London
Source:Eurekalert

Related medicine news :

1. David H. Koch donates $10 million to Mount Sinais Jaffe Food Allergy Institute
2. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
3. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
4. A North American first at the Montreal Heart Institute
5. UC Santa Barbaras Kavli Institute receives 2 grants to explore interface of physics and biology
6. Data release from the Allen Institute for Brain Science expands online atlas offerings
7. Los Robles Hospital’s Annual Health Fair Attended by Khanna Institute
8. Patient Experience Regional Roundtables Announced by The Beryl Institute
9. Stanford Woods Institute for the Environment announces 2012 Environmental Venture Project awards
10. Aetna Institute Designates RSC New England Center of Excellence
11. To tackle health cares thorniest problems, 400 health researchers form new U-M-based institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... It’s that time of year when ... president of the Interscholastic Athletic Association of Maryland (IAAM), Hall of Fame athlete and ... goals are cast aside. , That’s why one of her first decisions when her ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... businesses recover after a disaster, announced today the acquisition of Hawaii DKI. Hawaii ... , “Investing in like-minded companies who excel at service and response ...
(Date:2/9/2016)... MA (PRWEB) , ... February 09, 2016 , ... ... (WCRI) compares the workers’ compensation fee schedule rates and Medicare rates for a ... services covered in the report, Evaluation of the 2015 Fee Schedule Rates ...
(Date:2/9/2016)... ... February 09, 2016 , ... BioPlus Specialty Pharmacy (BioPlus), ... the ‘Pay It Forward’ program into 2016. BioPlus partners with several non-profit patient ... , “Since our Pay It Forward program began, we are proud to ...
(Date:2/9/2016)... ... 2016 , ... The Journal of Pain Research has published the ... , As corresponding author Dr John F. Peppin says “Terminology matters, yet little attention ... pain patients. ‘Chronic cancer pain’ and ‘chronic non-cancer pain’ are replete in the ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... BioSciences, Inc. (NASDAQ: SGMO ), the leader ... quarter and full year 2015 financial results and ... editing," said Edward Lanphier, Sangamo,s president and chief ... leads the therapeutic genome editing field and we ... our ground-breaking genome editing programs through IND enabling ...
(Date:2/9/2016)... QGEN ; Frankfurt Prime ... Genomics to develop and promote comprehensive solutions for ... --> QGEN ; Frankfurt Prime Standard: QIA) ... develop and promote comprehensive solutions for next-generation sequencing ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ...
(Date:2/9/2016)... --  AllCare Plus Pharmacy announced today that it ... ® for Home Care Accreditation by ... Seal of Approval ® is a symbol of ... and effective care.  --> ... on-site survey in January 2016. The survey reflected compliance ...
Breaking Medicine Technology: